| ||
| Clinical responses to EGFR-tyrosine kinase inhibitor retreatment ... By Google Inc. first epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) approved for the treatment of advanced non-small cell lung cancer (NSCLC). ... See all stories on this topic » mesotheliomaexpert.org Mesothelioma... - http://www.mesotheliomaexpert.org/ | ||
| Discovery and Preclinical Validation of Salivary Transcriptomic ... By PLoS ONE ... Technology for Early Detection of Lung Cancer · Face of Defense: Soldier Beats Breast Cancer With Early Detection · Systemic Disease-Induced Salivary Biomarker Profiles in Mouse Models of Melanoma and Non-Small Cell Lung Cancer ... Elites TV - http://elitestv.com/ |
| ||
| Neoplastic pulmonary cytology - Cohen - 2010 - Cancer ... Specific objective histologic classification in non small cell lung cancer ( NSCLC) cytology specimens. Cancer Cytopathol. 2010; 118( 5 suppl): 362. ... onlinelibrary.wiley.com/.../references?... |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment